The following is based on a press release.
Hospira Inc., a Pfizer company, is voluntarily recalling one lot (EA7470) of propofol injectable emulsion (100-mL single patient use glass flip-top vial) due to visible particulates observed in two vials during a recent annual examination of retention samples.
Patients who received the impacted product can potentially experience adverse events, including blockage of blood vessels, decreased blood flow to the brain, heart attack, pulmonary embolus and